1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update

Summary

MEDITE Cancer Diagnostics, Inc. (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, robotic coverslippers, and cytology screening systems. The company products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. The company is headquartered in Orlando, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MEDITE Cancer Diagnostics, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


MEDITE Cancer Diagnostics, Inc. Company Snapshot 6
MEDITE Cancer Diagnostics, Inc. Company Overview 6
MEDITE Cancer Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 7
MEDITE Cancer Diagnostics, Inc. - Pipeline Analysis Overview 10
Business Description 10
Key Facts 10
MEDITE Cancer Diagnostics, Inc. - Major Products and Services 11
MEDITE Cancer Diagnostics, Inc. Pipeline Products by Development Stage 12
MEDITE Cancer Diagnostics, Inc. Pipeline Products Overview 14
AIPS Imager 14
AIPS Imager Product Overview 14
AIPS Workstation 15
AIPS Workstation Product Overview 15
BreastPap 16
BreastPap Product Overview 16
Diagnostic Assay - Endometrial Cancer 17
Diagnostic Assay - Endometrial Cancer Product Overview 17
Diagnostic Assay - HPV 18
Diagnostic Assay - HPV Product Overview 18
Genetic Biomarker Assay - Cervical Cancer 19
Genetic Biomarker Assay - Cervical Cancer Product Overview 19
Genetic Biomarker Assay - Uterine Cancer 20
Genetic Biomarker Assay - Uterine Cancer Product Overview 20
Screening Assay - Anal Cancer 21
Screening Assay - Anal Cancer Product Overview 21
Screening Assay - Bladder Cancer 22
Screening Assay - Bladder Cancer Product Overview 22
Screening Assay - Breast Cancer 23
Screening Assay - Breast Cancer Product Overview 23
Screening Assay - Lung Cancer 24
Screening Assay - Lung Cancer Product Overview 24
Screening Assay - Oral Cancer 25
Screening Assay - Oral Cancer Product Overview 25
SoftKit 26
SoftKit Product Overview 26
MEDITE Cancer Diagnostics, Inc. - Key Competitors 27
MEDITE Cancer Diagnostics, Inc. - Key Employees 28
MEDITE Cancer Diagnostics, Inc. - Key Employee Biographies 29
MEDITE Cancer Diagnostics, Inc. - Locations And Subsidiaries 30
Head Office 30
Other Locations and Subsidiaries 30
Recent Developments 31
MEDITE Cancer Diagnostics, Inc., Recent Developments 31
Nov 17, 2015: MEDITE Cancer Diagnostics Reports a Profitable Third Quarter and Nine Month 2015 Results 31
May 11, 2015: MEDITE Cancer Diagnostics Reports 2014 Year End Results along with Expectations for 2015 31
Mar 20, 2015: MEDITE Cancer Diagnostics Announces Granted Patent "Lab-in-One Automation" System 33
Dec 11, 2014: MEDITE Cancer Diagnostics Becomes New Name for CytoCore 34
Nov 21, 2014: CytoCore Reports Record YTD And 3rd Quarter Sales 34
Jun 18, 2014: MEDITE Files U.S. GAAP Financial Statements 34
Nov 30, 2010: CytoCore Signs Distribution Agreement With Guangdong Prosper Channel 35
Apr 08, 2010: CytoCore Appoints Mauro Scimia To European Sales And Marketing Services 35
Feb 26, 2010: UCLA School Of Nursing Selects PadKit Collection Kit For Cytology Study Of Cervical Cancer 35
Aug 19, 2009: CytoCore Reports Q2 2009 Results 36
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
MEDITE Cancer Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 7
MEDITE Cancer Diagnostics, Inc. Pipeline Products by Equipment Type 7
MEDITE Cancer Diagnostics, Inc. Pipeline Products by Indication 9
MEDITE Cancer Diagnostics, Inc., Key Facts 10
MEDITE Cancer Diagnostics, Inc., Major Products and Services 11
MEDITE Cancer Diagnostics, Inc. Number of Pipeline Products by Development Stage 12
MEDITE Cancer Diagnostics, Inc. Pipeline Products Summary by Development Stage 13
AIPS Imager - Product Status 14
AIPS Imager - Product Description 14
AIPS Workstation - Product Status 15
AIPS Workstation - Product Description 15
BreastPap - Product Status 16
BreastPap - Product Description 16
Diagnostic Assay - Endometrial Cancer - Product Status 17
Diagnostic Assay - Endometrial Cancer - Product Description 17
Diagnostic Assay - HPV - Product Status 18
Diagnostic Assay - HPV - Product Description 18
Genetic Biomarker Assay - Cervical Cancer - Product Status 19
Genetic Biomarker Assay - Cervical Cancer - Product Description 19
Genetic Biomarker Assay - Uterine Cancer - Product Status 20
Genetic Biomarker Assay - Uterine Cancer - Product Description 20
Screening Assay - Anal Cancer - Product Status 21
Screening Assay - Anal Cancer - Product Description 21
Screening Assay - Bladder Cancer - Product Status 22
Screening Assay - Bladder Cancer - Product Description 22
Screening Assay - Breast Cancer - Product Status 23
Screening Assay - Breast Cancer - Product Description 23
Screening Assay - Lung Cancer - Product Status 24
Screening Assay - Lung Cancer - Product Description 24
Screening Assay - Oral Cancer - Product Status 25
Screening Assay - Oral Cancer - Product Description 25
SoftKit - Product Status 26
SoftKit - Product Description 26
MEDITE Cancer Diagnostics, Inc., Key Employees 28
MEDITE Cancer Diagnostics, Inc., Key Employee Biographies 29
MEDITE Cancer Diagnostics, Inc., Other Locations 30
MEDITE Cancer Diagnostics, Inc., Subsidiaries 30

List of Figures
MEDITE Cancer Diagnostics, Inc. Pipeline Products by Equipment Type 8
MEDITE Cancer Diagnostics, Inc. Pipeline Products by Development Stage 12

Companies Mentioned
TriPath Imaging, Inc.
Thermo Fisher Scientific Inc.
Sakura Finetek USA, Inc.
Leica Biosystems Nussloch Gmbh
Dako A/S
Cytyc Surgical Products

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in the US and the UK

  • December 2016
    12 pages
  • Pathology  

    Digestive Syste...  

    Cancer  

  • United States  

    United Kingdom  

View report >

Pathology Statistics in the US and the UK

  • December 2016
    13 pages
  • Pathology  

    Digestive Syste...  

  • United States  

    United Kingdom  

View report >

Cancer Statistics in Europe - Forecast

  • December 2016
  • Cancer  

  • Europe  

    World  

View report >

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.